Skip to main content

US ClosedU.S. Closed

FLNA: Filana Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies.

52W Range

2ndpctl

Volume

0.48×avg

Market Cap

44.88MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Filana Therapeutics, Inc.

FLNANASDAQ Global Market·USD·Closed

Filana Therapeutics, Inc.

FLNANASDAQ·USD·Closed

$0.93

+0.65%

$0.93

+$0.01 (0.65%)

52W Range

2ndpctl

Volume

0.48×avg

Mkt Cap

44.88MUSD

P/E

-1.1TTM

Div Yield

–ann